Seadrill Ltd (NYSE:SDRL) fell -5.06% in pre-market trading down to $7.50 following a sharp drop in oil prices today. Although oil increased last week, the drop today has reversed last week’s gains. Investors are worried about how oil prices will react this week given an oversupply and new concerns for China’s economy. China will release production figures for the month of August tomorrow and economists expect to see that activity has decelerated at the fastest pace in the last three years. Furthermore, OPEC’s inaction to change oil output quotas in the last year coupled with the possibility of higher output thanks to Iran’s new oil producing privileges are a source of worry for investors. According to TipRanks, only one analyst has weighed in on Seadrill in the last 3 months, giving the oil giant a bearish rating.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) jumped 2.15% in pre-market trading to $78.77 following news that the FDA granted priority review for the biopharmaceutical company’s pipeline drug; Obeticholic acid, or OCA, used to treat patients with the liver disease primary biliary cirrhosis (PBC). Priority review will accelerate the review timeline, meaning the review process will take six months as opposed to the standard ten months. The drug has already received fast-track designation in the U.S. and orphan drug status in both Europe and the U.S. The FDA has set a target date of February 29, 2016, by which they hope to review the drug’s New Drug Application. According to the 9 analysts polled by TipRanks in the last 3 months, 7 analysts are bullish on Intercept, 1 is neutral, and 1 is bearish. The average 12-month price target on the stock is $390.78, marking a potential 106% upside from where shares last closed.

Twitter Inc (NYSE:TWTR) spiked 2.50% in pre-market trading up to $27.50 after Robert Peck, analyst for SunTrust, upgraded the social media company from Neutral to Buy with a $38 price target. Peck notes that Twitter sentiment is currently down, but he is now cautiously optimistic given “a series of positive catalysts” and “attractive valuation with a strategic floor.” The analyst predicated his upgrade on “quick mgmt. clarification (likely ~Labor Day) and execution.” Peck concludes, “While TWTR has near term challenges and our [estimates] are in-line with [The Street], we think user metrics have at least stabilized and can grow from the below catalysts.” According to the 26 analysts polled by TipRanks in the last 3 months, 12 are bullish on Twitter and 14 are neutral. The average 12-month price target on the company is $41.52, marking a 55% potential upside from where shares last closed.

To view Robert Peck’s past ratings and performance history, click here.

Netflix, Inc. (NASDAQ:NFLX) shares are down -2% in pre-market trading to $115.25 after the video streaming website announced it is not renewing its distribution deal with Epix cable network. Consequently, Netflix will no longer have the rights to play several popular movies such as The Hunger Games and The Transformers. Rumors suggest that Netflix will replace Epix with a distribution deal with Hulu, or replace the content void with more Netflix original content. Netflix’s Chief Content Officer, Ted Sarandos, commented, “We’ve enjoyed a five year partnership with Epix, but our strategic paths are no longer aligned. Our focus has shifted to provide great movies and TV series for our members that are exclusive to Netflix. Epix focus is to make sure that their movies will be widely available for consumers through a variety of platforms.” According to the 26 analysts polled by TipRanks in the last 3 months, 20 are bullish on Netflix, 4 are neutral, and 2 are bearish. The average 12-month price target on the stock is $123.11, marking a 4.66% potential upside from where shares last closed.